Thetford Mines, June 1st, 2018 – KDA Group Inc. (TSXV: KDA) (“KDA Group” or the “Corporation”) is proud to announce an agreement with ZoomMed Inc. (TSXV: ZMD) (“ZoomMed”) whereby KDA Group can distribute under a non-exclusive license the ZRx Prescriber developed by ZoomMed in the United States.